We are live on
!
Find out more
PAI
Palo Alto Investors Portfolio holdings
AUM
$654M
1-Year Est. Return
77.8%
This Fund
S&P 500
This Quarter
Est. Return
+25.06%
1 Year Est. Return
+77.8%
3 Year Est. Return
+127.05%
5 Year Est. Return
+199.24%
10 Year Est. Return
+2,229.57%
AUM
$1.21B
AUM Growth
+$138M
(+13%)
Cap. Flow
-$5.83M
Cap. Flow
% of AUM
-0.48%
Top 10 Holdings %
Top 10 Hldgs %
71.65%
Holding
41
New
7
Increased
11
Reduced
13
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
+$15.7M |
| 2 |
ITMN
INTERMUNE INC
ITMN
|
+$13.3M |
| 3 |
OREX
Orexigen Therapeutics, Inc.
OREX
|
+$11.3M |
| 4 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
+$2.86M |
| 5 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$2.67M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CYBX
CYBERONICS INC
CYBX
|
+$16.1M |
| 2 |
VPHM
VIROPHARMA INC
VPHM
|
+$14.5M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$13.4M |
| 4 |
STAAR Surgical
STAA
|
+$10M |
| 5 |
AMAG
AMAG Pharmaceuticals
AMAG
|
+$3.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 41.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITMN
1
DELISTED
INTERMUNE INC
ITMN
| $148M | 12.22% |
4,418,662
+599,056
| +16% | +$13.3M |
|
|
AUXL
2
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $132M | 10.88% |
4,842,031
-41,848
| -0.9% | -$1.11M |
|
|
CYBX
3
DELISTED
CYBERONICS INC
CYBX
| $112M | 9.23% |
1,711,730
-239,851
| -12% | -$16.1M |
|
4
United Therapeutics
UTHR
$23.1B
| $104M | 8.56% |
1,101,028
+5,600
| +0.5% | +$573K |
|
|
CBST
5
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $100M | 8.28% |
1,369,211
+33,075
| +2% | +$2.47M |
|
|
QCOR
6
DELISTED
QUESTCOR PHARMA INC
QCOR
| $62.9M | 5.2% |
969,495
+5,500
| +0.6% | +$351K |
|
|
ABMD
7
DELISTED
Abiomed Inc
ABMD
| $57.3M | 4.74% |
2,202,289
-485,058
| -18% | -$13.4M |
|
8
Vanda Pharmaceuticals
VNDA
$302M
| $52.3M | 4.32% |
3,215,424
-23,200
| -0.7% | -$330K |
|
9
BioMarin Pharmaceuticals
BMRN
$12.4B
| $50.9M | 4.2% |
745,687
+4,600
| +0.6% | +$339K |
|
|
10
STAAR Surgical
STAA
$1.21B
| $48.8M | 4.03% |
2,593,653
-620,600
| -19% | -$10M |
|
|
KYTH
11
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $36M | 2.97% |
905,259
+4,700
| +0.5% | +$210K |
|
|
ANAC
12
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $31.5M | 2.6% |
1,572,078
-31,200
| -2% | -$605K |
|
|
AMAG
13
DELISTED
AMAG Pharmaceuticals
AMAG
| $31.2M | 2.58% |
1,614,536
-146,796
| -8% | -$3.12M |
|
|
ALIM
14
DELISTED
Alimera Sciences
ALIM
| $28.7M | 2.37% |
242,332
| – | – |
|
|
ARIA
15
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $27.9M | 2.3% |
3,458,624
+17,300
| +0.5% | +$135K |
|
|
SQNM
16
DELISTED
SEQUENOM INC NEW
SQNM
| $24M | 1.98% |
9,788,442
+393,815
| +4% | +$939K |
|
17
Prothena Corp
PRTA
$450M
| $20.4M | 1.69% |
532,918
-4,500
| -0.8% | -$145K |
|
18
Rigel Pharmaceuticals
RIGL
$750M
| $20.1M | 1.66% |
516,930
-4,770
| -0.9% | -$170K |
|
|
EIGR
19
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $17.8M | 1.47% |
+3,314
| New | +$15.7M |
|
|
MNTA
20
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $15.3M | 1.27% |
1,314,976
+157,700
| +14% | +$2.67M |
|
|
NPSP
21
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $13M | 1.08% |
435,200
-3,900
| -0.9% | -$134K |
|
|
CLVS
22
DELISTED
Clovis Oncology, Inc.
CLVS
| $12.9M | 1.07% |
186,900
| – | – |
|
|
QLTI
23
DELISTED
QLT Inc
QLTI
| $11.3M | 0.94% |
2,041,043
-12,268
| -0.6% | -$76K |
|
|
EXAS
24
DELISTED
Exact Sciences
EXAS
| $11M | 0.91% |
777,676
-8,100
| -1% | -$109K |
|
|
OREX
25
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $10.8M | 0.9% |
+166,902
| New | +$11.3M |
|
Similar funds
RRA
GPSPJS
W
DAS
AG
BL
CG
SCM
Palo Alto Investors's Q1 2014 Portfolio in Review
As of Q1 2014, Palo Alto Investors held 41 positions worth $1.21B, up 13% from $1.07B the previous quarter. Its ten largest holdings account for 72% of the portfolio.
Palo Alto Investors's Q1 2014 filing shows 7 new, 11 increased, 13 reduced and 2 closed positions. Its largest new stake was Eiger BioPharmaceuticals, Inc.: 3,314 shares worth $17.8M. The largest sale was CYBERONICS INC, an estimated $16.1M.
By sector, the portfolio is most concentrated in Healthcare at 42% of assets, down from 44% a quarter earlier.
- Palo Alto Investors's largest Q1 2014 buy was Eiger BioPharmaceuticals, Inc.: 3,314 shares worth $17.8M.
- Palo Alto Investors added most to INTERMUNE INC in Q1 2014, an estimated $13.3M increase.
- Palo Alto Investors's biggest Q1 2014 reduction was CYBERONICS INC, cutting an estimated $16.1M.
- Palo Alto Investors fully exited VIROPHARMA INC in Q1 2014, selling an estimated $14.5M.
- Palo Alto Investors's ten largest holdings make up 72% of its $1.21B portfolio in Q1 2014.
- Palo Alto Investors opened 7 new positions and closed 2 in Q1 2014.
- Palo Alto Investors's portfolio value rose 13% quarter-over-quarter to $1.21B.
Based on Palo Alto Investors's 13F filing for Q1 2014, filed 15 May 2014.